Minnesota atrial fibrillation company Atritech raises $30 million
The new $30 million investment will help the atrial fibrillation device maker Atritech complete a U.S. Food and Drug Administration review and launch its product in Europe.
Medtronic leads $47 million investment in hypertension company Ardian
Ardian is developing a catheter system that disrupts the sympathetic nerves in the kidneys, which will in turn reduce blood pressure. Clinical trials are expected next week.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.